{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:20:27Z","timestamp":1787948427016,"version":"build-2784847793"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cirrhosis produces a rebalanced hemostatic state that predisposes patients to bleeding and thrombosis. We evaluated hepatic outcomes associated with deep vein thrombosis (DVT), pulmonary embolism, and portal vein thrombosis (PVT) in patients with cirrhosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study using the Nationwide Readmissions Database from 2016 to 2022. Adults with cirrhosis identified during January index hospitalizations were followed through the end of the same calendar year and classified as having no thromboembolism, DVT, pulmonary embolism, or PVT. The primary outcome was liver transplantation. Secondary outcomes included in-hospital mortality, ascites, esophageal or gastric varices, variceal hemorrhage, acute liver failure, and hepatic decompensation. Survey-weighted logistic regression estimated adjusted odds ratios (aORs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The weighted cohort included 365 467 patients: 363 007 without thromboembolism, 730 with DVT, 1036 with pulmonary embolism, and 694 with PVT. DVT was associated with lower odds of liver transplantation [aOR, 0.19; 95% confidence interval (CI), 0.05\u20130.83] and mortality (aOR, 0.54; 95% CI, 0.37\u20130.77). Pulmonary embolism was associated with lower odds of varices, ascites, acute liver failure, and hepatic decompensation. PVT was associated with higher odds of varices (aOR, 2.47; 95% CI, 1.95\u20133.13) and variceal hemorrhage (aOR, 2.83; 95% CI, 1.59\u20135.02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Thrombotic phenotypes in cirrhosis have distinct prognostic associations. PVT was associated with portal hypertensive complications, whereas apparently favorable associations with DVT and pulmonary embolism should be interpreted cautiously.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/meg.0000000000003255","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:00:10Z","timestamp":1787947210000},"page":"1205-1212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessing clinical outcomes in cirrhotic patients with thromboembolic complications"],"prefix":"10.1097","volume":"38","author":[{"given":"Martin C.","family":"Banks","sequence":"first","affiliation":[{"name":"Department of Medicine, Bayhealth Medical Center, Dover, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaobi","family":"Ahanotu","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Maryland, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Jung","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan","family":"Abougergi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Inova Fairfax Gastroenterology, Falls Church, Virginia"},{"name":"Catalyst Medical Consulting, Simpsonville, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"R1-20260828","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases.","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"R2-20260828","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.jhep.2021.11.004","article-title":"Haemostatic alterations and management of haemostasis in patients with cirrhosis.","volume":"76","author":"Lisman","year":"2022","journal-title":"J Hepatol"},{"key":"R3-20260828","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jtha.2024.05.023","article-title":"Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.","volume":"22","author":"Carlin","year":"2024","journal-title":"J Thromb Haemost"},{"key":"R4-20260828","doi-asserted-by":"crossref","first-page":"e25439","DOI":"10.1097\/MD.0000000000025439","article-title":"Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: a systematic review and meta-analysis.","volume":"100","author":"Xian","year":"2021","journal-title":"Medicine (Baltim)"},{"key":"R5-20260828","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.cgh.2020.02.037","article-title":"Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation.","volume":"18","author":"Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-20260828","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis.","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"R7-20260828","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2024.10.038","article-title":"AGA clinical practice update on management of portal vein thrombosis in patients with cirrhosis: expert review.","volume":"168","author":"Davis","year":"2025","journal-title":"Gastroenterology"},{"key":"R8-20260828","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1055\/s-0039-1697682","article-title":"Venous thromboembolism in patients with liver cirrhosis: findings from the RIETE (Registro Informatizado de la Enfermedad TromboEmbolica) registry.","volume":"45","author":"Bikdeli","year":"2019","journal-title":"Semin Thromb Hemost"},{"key":"R9-20260828","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.3748\/wjg.v20.i19.5737","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review.","volume":"20","author":"Aggarwal","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R10-20260828","doi-asserted-by":"crossref","first-page":"e0155337","DOI":"10.1371\/journal.pone.0155337","article-title":"Differential kinetics of coagulation factors and natural anticoagulants in patients with liver cirrhosis: potential clinical implications.","volume":"11","author":"Tischendorf","year":"2016","journal-title":"PLoS One"},{"key":"R11-20260828","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/hep.32019","article-title":"Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a Danish nation-wide cohort study.","volume":"74","author":"Jepsen","year":"2021","journal-title":"Hepatology"},{"key":"R12-20260828","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/hep.31201","article-title":"Hemostatic alterations in patients with cirrhosis: from primary hemostasis to fibrinolysis.","volume":"71","author":"Zermatten","year":"2020","journal-title":"Hepatology"},{"key":"R13-20260828","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1345\/aph.1Q726","article-title":"Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.","volume":"46","author":"Pincus","year":"2012","journal-title":"Ann Pharmacother"},{"key":"R14-20260828","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1155\/2012\/175849","article-title":"Venous thromboembolism in cirrhosis: a review of the literature.","volume":"26","author":"Buresi","year":"2012","journal-title":"Can J Gastroenterol"}],"container-title":["European Journal of Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MEG.0000000000003255","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:00:12Z","timestamp":1787947212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MEG.0000000000003255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/meg.0000000000003255","relation":{},"ISSN":["0954-691X","1473-5687"],"issn-type":[{"value":"0954-691X","type":"print"},{"value":"1473-5687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"2026-03-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}